Live RSS
Federal Grant · National Institutes of Health

Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)

Last verified by NonDilute: 2026-06-08. Official notice and agency instructions control.

Healthcare TechBiotech university-researchernon-profitsmall-business
The pitch

If you're leading a multidisciplinary research team with Latin American partners ready to run a clinical trial on chronic disease disparities, this R01 funds the full scope with broad eligibility.

Award range
Unspecified
Closes
May 7, 2027 · 333d left
Open date
Jan 13, 2025
Difficulty
High
Source
Grants.gov
Agency
National Institutes of Health
Last verified
2026-06-08
Fit language
Possible fit only
Apply at grants.gov →

Report stale or inaccurate summary

What this is

This R01 grant supports multidisciplinary research addressing non-communicable and chronic diseases with the highest burden in Latin America and U.S. Hispanic/Latino communities. Applicants must form teams with at least one PI or MPI from Latin American institutions and conduct clinical trials. The program emphasizes health disparities, community-based approaches, and international collaboration across a wide range of eligible organization types.

Who can apply

Highly inclusive: nonprofits (501(c)(3) and non-501(c)(3)), for-profit entities (including small businesses), universities, government agencies, tribal organizations, and others all eligible. Critical requirement: research team must include at least one PI or MPI from a Latin American institution. U.S.-based applicants can lead if they partner internationally.

Eligible applicant types

Full description — from the agency

The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative and interdisciplinary research teams focused on clinical, health services, and/or community-based interventions that address health and healthcare disparities related to non-communicable and chronic diseases (NCDs) with the highest burden and mortality in Latin America and among U.S. Hispanics/Latinos. Multidisciplinary research teams would be expected to meaningfully collaborate with key partners that must include at least one PI or MPI from institutions in Latin America.

Topics: health disparities · chronic disease intervention · latin america · clinical trial · hispanic latino health · non-communicable disease

Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.